In the latest session, Cigna Group (NYSE: CI) closed at $332.96 down -0.95% from its previous closing price of $336.14. In other words, the price has decreased by -$3.18 from its previous closing price. On the day, 1473072 shares were traded.
Ratios:
For a deeper understanding of Cigna Group’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on February 05, 2024, Upgraded its rating to Outperform and sets its target price to $354 from $327 previously.
On February 05, 2024, Cantor Fitzgerald Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $334 to $372.
Deutsche Bank Upgraded its Hold to Buy on February 01, 2024, whereas the target price for the stock was revised from $355 to $370.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 27 when Cordani David sold 2,000 shares for $345.04 per share. The transaction valued at 690,075 led to the insider holds 336,783 shares of the business.
Cordani David sold 10,453 shares of CI for $3,613,652 on Feb 26. The Chairman & CEO now owns 336,783 shares after completing the transaction at $345.70 per share. On Feb 23, another insider, Cordani David, who serves as the Chairman & CEO of the company, sold 6,319 shares for $345.24 each. As a result, the insider received 2,181,592 and left with 336,783 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 97.39B and an Enterprise Value of 120.04B. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.15, and their Forward P/E ratio for the next fiscal year is 10.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.50 while its Price-to-Book (P/B) ratio in mrq is 2.11. Its current Enterprise Value per Revenue stands at 0.63.
Stock Price History:
Over the past 52 weeks, CI has reached a high of $347.14, while it has fallen to a 52-week low of $240.50. The 50-Day Moving Average of the stock is 316.58, while the 200-Day Moving Average is calculated to be 291.20.
Shares Statistics:
For the past three months, CI has traded an average of 2.05M shares per day and 1.63M over the past ten days. A total of 292.50M shares are outstanding, with a floating share count of 287.10M. Insiders hold about 1.80% of the company’s shares, while institutions hold 88.84% stake in the company. Shares short for CI as of Feb 15, 2024 were 7.26M with a Short Ratio of 3.54, compared to 3.51M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.48% and a Short% of Float of 2.49%.
Dividends & Splits
According to the company, the forward annual dividend rate for CI is 4.92, from 4.92 in the trailing year. Against a Trailing Annual Dividend Yield of 1.46%, it implies a Forward Annual Dividend Yield of 1.68%. The stock’s 5-year Average Dividend Yield is 0.87. The current Payout Ratio is 28.29% for CI, which recently paid a dividend on Mar 21, 2024 with an ex-dividend date of Mar 05, 2024. Stock splits for the company last occurred on Jun 05, 2007 when the company split stock in a 3:1 ratio.
Earnings Estimates
There are 19 different market analysts currently analyzing its stock. On average, analysts expect EPS of $6.21 for the current quarter, with a high estimate of $6.54 and a low estimate of $6.04, while EPS last year was $5.41. The consensus estimate for the next quarter is $6.93, with high estimates of $7.75 and low estimates of $6.55.
Analysts are recommending an EPS of between $29.04 and $28.17 for the fiscal current year, implying an average EPS of $28.41. EPS for the following year is $32.03, with 20 analysts recommending between $32.73 and $31.48.
Revenue Estimates
A total of 16 analysts believe the company’s revenue will be $56.52B this quarter.It ranges from a high estimate of $57.75B to a low estimate of $55.57B. As of the current estimate, Cigna Group’s year-ago sales were $46.48B, an estimated increase of 21.60% from the year-ago figure. For the next quarter, 16 analysts are estimating revenue of $58.46B, an increase of 20.30% less than the figure of $21.60% in the same quarter last year. There is a high estimate of $61.05B for the next quarter, whereas the lowest estimate is $57.34B.
A total of 19 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $245.61B, while the lowest revenue estimate was $231.11B, resulting in an average revenue estimate of $235.53B. In the same quarter a year ago, actual revenue was $195.26B, up 20.60% from the average estimate. Based on 19 analysts’ estimates, the company’s revenue will be $245.78B in the next fiscal year. The high estimate is $251.72B and the low estimate is $234.03B. The average revenue growth estimate for next year is up 4.40% from the average revenue estimate for this year.
